ENDRA Life Sciences (NDRA) EPS (Basic) (2016 - 2021)
Historic EPS (Basic) for ENDRA Life Sciences (NDRA) over the last 6 years, with Q4 2021 value amounting to -$5.35.
- ENDRA Life Sciences' EPS (Basic) fell 446194.19% to -$5.35 in Q4 2021 from the same period last year, while for Dec 2021 it was -$5.55, marking a year-over-year decrease of 77877.57%. This contributed to the annual value of -$4.56 for FY2022, which is 1783.78% up from last year.
- Per ENDRA Life Sciences' latest filing, its EPS (Basic) stood at -$5.35 for Q4 2021, which was down 446194.19% from -$0.06 recorded in Q3 2021.
- ENDRA Life Sciences' EPS (Basic)'s 5-year high stood at -$0.06 during Q1 2021, with a 5-year trough of -$5.35 in Q4 2021.
- Its 5-year average for EPS (Basic) is -$0.69, with a median of -$0.42 in 2019.
- In the last 5 years, ENDRA Life Sciences' EPS (Basic) soared by 9025.86% in 2020 and then plummeted by 446194.19% in 2021.
- Quarter analysis of 5 years shows ENDRA Life Sciences' EPS (Basic) stood at -$0.83 in 2017, then skyrocketed by 36.91% to -$0.53 in 2018, then tumbled by 129.26% to -$1.2 in 2019, then skyrocketed by 90.26% to -$0.12 in 2020, then plummeted by 4461.94% to -$5.35 in 2021.
- Its EPS (Basic) was -$5.35 in Q4 2021, compared to -$0.06 in Q3 2021 and -$0.08 in Q2 2021.